Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria

BACKGROUND: Mycobacterium tuberculosis with resistance to first line and second line anti tuberculous drugs is a serious setback in the treatment of tuberculosis (TB). The COVID-19 pandemic constitutes a serious threat that could unwind the recent gains made thus far in the control of tuberculosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad Dayyab, Farouq, Iliyasu, Garba, Garba Ahmad, Bashir, Aliyu Umar, Ibrahim, Musa Shuaib, Nura, Bajehson, Mamman, Muhammad Daiyab, Ibrahim, Akpala, Oji, Remilekun, Olaoye, Garba Habib, Abdulrazaq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110314/
https://www.ncbi.nlm.nih.gov/pubmed/35599722
http://dx.doi.org/10.1016/j.jctube.2022.100319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110314/
https://www.ncbi.nlm.nih.gov/pubmed/35599722
http://dx.doi.org/10.1016/j.jctube.2022.100319

Ejemplares similares